Health
T cells target broad range of SARS-CoV-2 epitopes, study shows – Drug Target Review
A study has found that T cells combat SARS-CoV-2 by targeting many sites on the coronavirus, not just the Spike protein.
Posted: 29 January 2021 | Victoria Rees (Drug Target Review) | No comments yet
A study has found that T cells combat SARS-CoV-2 by targeting many sites on the coronavirus, not just the Spike protein.
A new study has suggested that T cells combat SARS-CoV-2 by targeting a broad range of sites on the virus, beyond the key sites on the virus’s Spike (S) protein. By attacking the coronavirus from many angles, the body can potentially recognise different SARS-CoV-2 variants. The study was led by scientists…
-
Noosa News12 hours agoTeenage girl dies in hit-and-run, police hunt for ute
-
Noosa News7 hours agoArnie the dog found dead in stolen ute after week of searching
-
Noosa News14 hours agoTeenage girl killed in alleged hit-and-run at Margate north of Brisbane
-
Noosa News7 hours ago‘Beyond devastated’ Brisbane family learn missing German shepherd Arnie found dead in back of stolen car